Share on StockTwits

Synthetic Biologics (NYSE:SYN) issued its quarterly earnings data on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.02, ARN reports.

Synthetic Biologics (NYSE:SYN) opened at 1.81 on Thursday. Synthetic Biologics has a 52-week low of $0.95 and a 52-week high of $3.64. The stock’s 50-day moving average is $1.63 and its 200-day moving average is $2.. The company’s market cap is $105.8 million. Synthetic Biologics also was the target of a significant increase in short interest in July. As of July 31st, there was short interest totalling 2,224,409 shares, an increase of 16.5% from the July 15th total of 1,910,147 shares. Based on an average daily volume of 919,491 shares, the days-to-cover ratio is currently 2.4 days. Currently, 7.0% of the company’s shares are short sold.

Synthetic Biologics, Inc, formerly Adeona Pharmaceuticals, Inc, is a biotechnology company focused on the development of synthetic deoxyribonucleic acid (NYSE:SYN)-based therapeutics and disease-modifying medicines for serious illnesses.

Receive News & Ratings for Synthetic Biologics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthetic Biologics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.